- Home
- MHO vs ACLX Comparison
MHO vs ACLX Comparison
Compare MHO & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MHO | ACLX |
|---|---|---|
| Founded | 1976 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.7B |
| IPO Year | 1986 | 2022 |
Fundamental Metrics
Financial Performance| Metric | MHO | ACLX |
|---|---|---|
| Price | $146.28 | $67.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $157.00 | $113.75 |
| AVG Volume (30 Days) | 251.7K | ★ 856.7K |
| Earning Date | 01-28-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 14.74 | N/A |
| Revenue | ★ $4,417,781,000.00 | $35,898,000.00 |
| Revenue This Year | $0.66 | N/A |
| Revenue Next Year | $6.97 | $309.32 |
| P/E Ratio | $9.62 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $100.22 | $47.86 |
| 52 Week High | $158.92 | $94.07 |
Technical Indicators
Market Signals| Indicator | MHO | ACLX |
|---|---|---|
| Relative Strength Index (RSI) | 66.23 | 46.76 |
| Support Level | $132.21 | $66.44 |
| Resistance Level | $145.18 | $71.25 |
| Average True Range (ATR) | 5.04 | 2.72 |
| MACD | 1.02 | 0.03 |
| Stochastic Oscillator | 95.37 | 26.48 |
Price Performance
Historical ComparisonAbout MHO M/I Homes Inc.
M/I Homes Inc is an American construction company that focuses on residential construction. It consists of two distinct operations: homebuilding and financial services. The homebuilding operations are spread into the Midwest, Mid-Atlantic, and Southern regions, and the financial services operations support homebuilding operations by providing mortgage loans and title services to the customers of homebuilding operations. Homebuilding operations comprise a predominant portion of the revenue. The company builds homes and communities that target entry-level, move-up, and luxury homebuyers.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.